News Archive
New Therapies Being Developed for Children with Muscular Dystrophy Are Offering Hope
Dey, a faculty researcher at The RNA Institute at the University at Albany, was recently awarded the American Heart Association’s (AHA) prestigious Scientist Development Grant to gain a better understanding of DMD and develop RNA-based therapy treatments that can potentially fight the disease.
Heart Association Awards Grant to University Scientist for Development of New Duchenne Therapies
The American Heart Association (AHA) has awarded its distinguished Scientist Development Grant to a University at Albany researcher for the development of new therapies to treat Duchenne muscular dystrophy (DMD). Bijan K. Dey, PhD, is a faculty researcher at the university’s RNA Institute and is working on a class of small non-coding RNA molecules called microRNAs. His lab is studying how microRNAs maintain normal muscle function and what goes wrong when children are diagnosed with Duchenne MD and associated heart conditions.
Scientist Awarded AHA Grant to Develop Therapies for Rare Form of Childhood Muscular Dystrophy
Scientist Bijan K. Dey could soon offer hope to young patients with a rare form of muscular dystrophy.